Dr. Om Sambhaji Shelke | Operations Research and Statistical Optimization | Excellence in Research Award
Sinomune Pharmaceutical Co. Ltd | China
Dr. Om Sambhaji Shelke is a highly accomplished pharmaceutical scientist with extensive expertise in the formulation and development of topical, semisolid, solid, and liquid drug products. Holding a Ph.D. in Pharmacy and an M. Pharmacy from Savitribai Phule Pune University, he has over a decade of experience across global markets including the US, EU, China, Hong Kong, and India. Currently serving as Chief Scientist at Sinomune Pharmaceutical Co. Ltd. in Wuxi, Jiangsu, China, Dr. Shelke leads the development of generic topical products for the NMPA market. He is skilled in Quality by Design (QbD)-based development of creams, ointments, gels, shampoos, and solutions, with specialization in novel formats such as emulgel, organogel, nanogel, solid lipid nanoparticles, suspensions, and toothpaste. He also holds three granted patents and has published multiple scientific and technical articles. Throughout his career, he has received multiple awards recognizing his innovation, knowledge sharing, and leadership, including the StarFire Award. Dr. Shelke has held pivotal roles at leading pharmaceutical and consumer healthcare companies such as Prinbury Biopharm Co. Ltd., Encube Ethicals Pvt Ltd., Bright Future Pharmaceuticals Ltd., Unilever Industries Pvt Ltd., Abbott Healthcare Pvt Ltd., Dr. Reddy’s Laboratories, and Glenmark Pharmaceuticals Ltd., contributing to both regulatory-compliant NDA, ANDA, and 505(b)(2) products as well as OTC, cosmetic, and personal care formulations. His professional journey reflects a consistent commitment to scientific excellence, innovative product development, and leadership in cross-functional teams, positioning him as a prominent figure in global pharmaceutical research and development.
Profiles: Google Scholar | Orcid
Featured Publications
F. Jie, O. Shelke, Z. Yijie, C. Yulan, & L. Yongbo. (2025). Q1 and Q2 selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation of topical generic product. Drug Development and Industrial Pharmacy, 51(6), 555–565.
J. Feng, O. S. Shelke, Y. Chen, Z. Zhang, X. Tang, & Y. Zhu. (2025). IVRT and IVPT of desonide lotion and cream: Correlation with human bioequivalence study. Journal of Pharmaceutical Innovation, 20(5), 196.
S. Krishna Phani Chandra, S. Om Sambhaji, & N. Shorgar. (2025). Quantification of leniolisib in rat plasma using LC-MS/MS: Method development, validation, and pharmacokinetic study. African Journal of Biological Sciences, 7(7), 121–142.
S. Om. (2025). Editorial article: The transformative impact of AI in pharmaceutical drug product development. Insights of Pharmatech, 1(2), 1.
S. Gadge, O. S. Shelke, R. Pingale, P. Palande, S. Tandale, P. Sonawane, … (2025). Development and evaluation of a polyherbal neem-based emulgel enriched with herbal oils for enhanced topical delivery and antibacterial efficacy. Journal of Chemical Health Risks, 15(3), 2189–2209.